PHAARMASIA LTD. Share Price

PHAARMASIA LTD. Share Price

BSE: 523620
|
Pharmaceuticals
|
S Cap
₹ 90.30
-₹4.75 (-5%)
1D
Last updated 02 Sep, 2026, 14:44 IST

PHAARMASIA LTD. Share Price Today

As of 3 Sep 2026, PHAARMASIA LTD. share price is ₹90.30. The stock opened at ₹95.05, compared to its previous close of ₹95.05. During today's trading session, PHAARMASIA LTD. share price moved in the range of ₹90.30 to ₹95.05, with an average price of ₹92.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.01 and a high of ₹131.75.

₹90.30
5.00% down today
₹95.05
1D LOW
1D HIGH

PHAARMASIA LTD. Returns Calculator

Circuit
L
H
₹85.80
₹94.80
52-week
L
H
₹30.01
₹131.75

About PHAARMASIA LTD.

PHAARMASIA LTD. Share Price
ISIN
INE486I01016
Sector Market Cap
₹ 61.67 Cr

Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.

PHAARMASIA LTD. Financial Highlights

  • Revenue: PHAARMASIA LTD. reported revenue of ₹48.17 crore in FY26 vs ₹25.12 crore in FY25. It showed an increase of 91.76% on a yearly basis.
  • Operating Profit: PHAARMASIA LTD. reported an operating profit of ₹21.39 crore in FY26 vs ₹1.60 crore in FY25. It showed an increase of 1,436.88% on a year-on-year basis.
  • Net Profit: PHAARMASIA LTD. reported a net profit of ₹17.57 crore in FY26 vs ₹1.59 crore in FY25. It showed an increase of 1,205.03% on a yearly basis.

PHAARMASIA LTD. Quarterly Result Highlights

  • PHAARMASIA LTD. reported revenue of ₹8.58 crore in Jun 2026, compared with ₹8.07 crore in Mar 2026, representing an increase of 6.32% on a quarter-on-quarter (QoQ) basis.
  • PHAARMASIA LTD. reported an operating profit of ₹0.30 crore in Jun 2026, compared with ₹0.54 crore in Mar 2026, representing an increase of 155.56% on a quarter-on-quarter (QoQ) basis.
  • PHAARMASIA LTD. reported a profit of ₹0.34 crore in Jun 2026, compared with ₹0.70 crore in Mar 2026, reflecting an increase of 148.57% on a QoQ basis.
  • The earnings per share (EPS) of PHAARMASIA LTD. stood at ₹2.33 during Jun 2026.
Know more
Promoters
73.51%
FII
0.00%
Other DII
0.06%
Retail and other
26.43%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
61.67
P/E
3.50
P/B
3.45
ROE
8.93%
D/E
0.05
ROCE
11.29%
Div. Yield
0.00%
EPS(TTM)
25.74
Turnover
1.62
EV/EBITDA
2.53
Net Margin
0.00%
Op. Margin
0.00%
ROA
58.72%
Quick Ratio
0.00
Curr. Ratio
4.05
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Phaarmasia outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Phaarmasia appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

PHAARMASIA LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹24.37₹30.59₹27.49₹17.22
Other Income₹0.75₹0.66₹0.52₹0.47
Total Revenue₹25.12₹31.25₹28.01₹17.69
Total Expenses₹26.72₹31.80₹29.44₹19.25
Profit Before Tax-₹1.60-₹0.55-₹1.43-₹1.56
Tax-₹0.01-₹0.03-₹0.17-₹0.02
Profit After Tax-₹1.59-₹0.52-₹1.26-₹1.55
EPS - Basic-₹2.33-₹0.76-₹1.84-₹2.27
EPS - Diluted-₹2.33-₹0.76-₹1.84-₹2.27

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹1.60-₹0.55-₹1.43-₹1.56
Income before WC changes-₹1.32-₹0.19-₹1.06-₹1.32
Change in Assets₹9.48-₹3.37-₹6.66₹0.25
Change in Liabilities-₹8.16₹3.67₹8.37₹1.07
Change in WC₹1.32₹0.30₹1.71₹1.32
Cash flow from Operations₹0.00₹0.11₹0.65-₹0.17
Cash flow from Investing-₹0.12₹0.00-₹0.01₹0.00
Cash flow from Financing-₹0.15-₹0.16-₹0.16₹0.00
Total Cash Flow-₹0.27-₹0.06₹0.48-₹0.17
Cash (Start of the year)₹0.63₹0.69₹0.22₹0.38
Cash (End of the year)₹0.36₹0.63₹0.69₹0.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹13.35₹13.48₹13.38₹12.90
Current Assets₹8.21₹17.97₹15.04₹8.30
Total Assets₹21.56₹31.45₹28.42₹21.21
Current Liabilities₹12.61₹20.91₹17.28₹8.88
Net Current Asset-₹4.40-₹2.94-₹2.23-₹0.58
Non-Current Liabilities₹0.22₹0.24₹0.33₹0.27
Equity Capital₹8.74₹10.30₹10.81₹12.06
Total Equity & Liabilities₹21.56₹31.45₹28.42₹21.21
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
90.3
2114
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2114
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
54.36
Neutral
ATR (14)
6.78
Neutral
STOCH(9,6)
49.4
Neutral
STOCH RSI (14)
65.53
Neutral
ADX(9)
36.72
Bearish
UO(9)
52.39
Neutral
ROC(12)
17.84
Bullish
WillR(14)
-38.6
Neutral
Period
Simple value
Exponential vaue
5D
93.57
91.48
10D
85.53
88.02
20D
82.77
85.87
50D
89.04
87.4
100D
90.86
91.29
Volume trend — traded volume by day
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
PHAARMASIA LTD. Share Price
PHAARMASIA LTD.
Pharmaceuticals
Add Stock
Add Another

PHAARMASIA LTD. Share Price FAQs